Form 4: Thermo Fisher Scientific Executive Acquires Shares Following Performance-Based Vesting

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, acquired 2,611 shares of common stock following the satisfaction of performance criteria related to a restricted stock unit award.

Summary

• Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, filed a Form 4 indicating changes in beneficial ownership.
• On February 19, 2025, Mr. Boxer acquired 2,611 shares of Thermo Fisher Scientific common stock.
• This acquisition resulted from the vesting of a performance-based restricted stock unit award granted on February 21, 2024.
• The company's Compensation Committee determined that the performance criteria for this award were met.
• One-third of the shares vest on February 28, 2025 and 2026, with the remaining one-third vesting on February 28, 2027, subject to adjustment based on long-term performance relative to a peer group.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the vesting of performance-based stock units suggests the company is meeting its performance goals. The executive's increased stake aligns interests with shareholders.

Positives

• The vesting of performance-based restricted stock units suggests that the company has met certain performance targets set by the Compensation Committee.
• The executive's increased stake in the company aligns his interests with those of shareholders.

Risks

• The final tranche of the award is subject to adjustment based on the company's performance relative to its peer group, introducing uncertainty regarding the final number of shares that will vest.

Future Outlook

The final vesting tranche in February 2027 is subject to adjustment based on the company's total shareholder return CAGR compared to its peer group between January 1, 2024, and December 31, 2026.

Industry Context

Executive stock ownership is common in publicly traded companies like Thermo Fisher Scientific to align management's interests with those of shareholders. Performance-based vesting is a mechanism to incentivize executives to achieve specific financial or strategic goals.

Comparison to Industry Standards

• Thermo Fisher Scientific's use of performance-based restricted stock units is a common practice among large, publicly traded companies to incentivize executive performance.
• Peer group comparisons for TSR are frequently used in executive compensation plans to ensure that executives are rewarded for outperforming their competitors.
• Companies like Danaher, Agilent Technologies, and PerkinElmer, which are often considered peers of Thermo Fisher Scientific, also utilize similar performance-based compensation structures.

Stakeholder Impact

• Shareholders may view the vesting of performance-based stock units positively, as it suggests that the company is meeting its performance goals.
• Employees may be motivated by the company's success and the alignment of executive incentives with shareholder value.

Next Steps

• The final tranche of the award will vest on February 28, 2027, subject to adjustment based on the company's performance relative to its peer group.
• Continued monitoring of Thermo Fisher Scientific's performance relative to its peer group will be necessary to determine the final number of shares that will vest.

Key Dates

Keywords

Thermo Fisher Scientific, Form 4, Beneficial Ownership, Michael A. Boxer, Restricted Stock Unit, Vesting, Performance-Based Award, Compensation Committee, Shareholder Return